|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
AS |
$112.07 |
$478,121 |
D/D |
(4,250) |
117,264 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-04-27 |
4 |
AS |
$127.49 |
$7,952,758 |
D/D |
(61,480) |
127,515 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-05-15 |
4 |
AS |
$123.85 |
$18,330 |
D/D |
(148) |
127,515 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-08-05 |
4 |
AS |
$140.51 |
$2,801,202 |
D/D |
(19,828) |
127,515 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-09-04 |
4 |
AS |
$124.43 |
$1,139,818 |
D/D |
(9,063) |
127,515 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-10-01 |
4 |
AS |
$102.30 |
$1,300,225 |
D/D |
(12,417) |
115,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-10-30 |
4 |
AS |
$123.36 |
$1,298,794 |
D/D |
(10,350) |
104,748 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-05 |
4 |
AS |
$122.46 |
$771,622 |
D/D |
(6,264) |
104,748 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
AS |
$121.95 |
$504,852 |
D/D |
(4,077) |
104,464 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-12-04 |
4 |
AS |
$123.53 |
$561,748 |
D/D |
(4,531) |
104,464 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2016-02-03 |
4 |
AS |
$89.92 |
$548,759 |
D/D |
(6,042) |
115,721 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2016-10-03 |
4 |
AS |
$86.46 |
$104,444 |
D/D |
(1,208) |
114,566 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2016-11-09 |
4 |
AS |
$90.00 |
$108,720 |
D/D |
(1,208) |
113,358 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-02-13 |
4 |
AS |
$88.39 |
$335,175 |
D/D |
(3,792) |
127,455 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-04-28 |
4 |
AS |
$119.50 |
$3,384,240 |
D/D |
(28,320) |
131,247 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-01 |
4 |
AS |
$124.00 |
$1,685,656 |
D/D |
(13,594) |
131,467 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-02 |
4 |
AS |
$129.02 |
$7,402,523 |
D/D |
(57,375) |
131,467 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-19 |
4 |
AS |
$161.00 |
$14,441,830 |
D/D |
(89,400) |
131,467 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-21 |
4 |
AS |
$159.00 |
$2,011,271 |
D/D |
(12,475) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-31 |
4 |
AS |
$152.99 |
$325,104 |
D/D |
(2,125) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
AS |
$155.72 |
$661,810 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
AS |
$152.88 |
$649,740 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-27 |
4 |
AS |
$141.41 |
$905,598 |
D/D |
(6,290) |
116,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-31 |
4 |
AS |
$142.18 |
$10,860,645 |
D/D |
(75,000) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
AS |
$148.17 |
$629,723 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
192 Records found
|
|
Page 2 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|